Adverse events after intravitreal infliximab (Remicade).

@article{Giganti2010AdverseEA,
  title={Adverse events after intravitreal infliximab (Remicade).},
  author={Monica Giganti and Paul M. Beer and Nicole Lemanski and Coby L Hartman and Jerome P Schartman and Naomi S. Falk},
  journal={Retina},
  year={2010},
  volume={30 1},
  pages={
          71-80
        }
}
  • Monica Giganti, Paul M. Beer, +3 authors Naomi S. Falk
  • Published in Retina 2010
  • Medicine
  • PURPOSE To determine the tolerability of intravitreal infliximab (Remicade) in patients with refractory diabetic macular edema or choroidal neovascularization secondary to age-related macular degeneration. METHODS This is a prospective, interventional, noncomparative, open-label, 12-week pilot study of intravitreal infliximab in four patients who failed conventional therapies. Two had diabetic macular edema and two had choroidal neovascularization secondary to age-related macular degeneration… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 62 CITATIONS, ESTIMATED 51% COVERAGE

    Management of noninfectious posterior uveitis with intravitreal drug therapy

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Intravitreal tumor necrosis factor-alpha inhibitors for neovascular age-related macular degeneration suboptimally responsive to antivascular endothelial growth factor agents: a pilot study from the Pan American Collaborative Retina Study Group.

    VIEW 4 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    Intravitreal Infliximab for Choroidal Neovascularization in Patients Refractory to Conventional Treatments

    VIEW 3 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    FILTER CITATIONS BY YEAR

    2010
    2019

    CITATION STATISTICS

    • 5 Highly Influenced Citations